Tradestie Institutional Equity Comparison Engine
PBE vs PJP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PJP Overall Edge
PJP Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco Pharmaceuticals ETF (PJP) driven by superior Momentum & Technical while PBE counters with relative strength in Options & Structure. Fundamentally, PBE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PJP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PBE sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PJP sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PBE N/M vs PJP N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
PJP
1Y +23.9% vs +28.1% ยท 52W Pos 71% vs 93%
Options & Structure Winner
PBE
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (2nd %ile IV)
PBE
NYSE Arca
Invesco Biotechnology & Genome ETF
Institutional Equity
$96.22
-1.7% 1D
Market Cap
N/A
1M Return
+0.15%
1Y Return
+23.93%
Forward P/E
N/M
Unified AI Score
53.2 / 100
HOLD
Tech 41.0
Fund 44.0
Flow 50.0
Mom 41.1
PJP
NYSE Arca
Invesco Pharmaceuticals ETF
Institutional Equity
$130.10
-0.72% 1D
Market Cap
N/A
1M Return
+4.53%
1Y Return
+28.09%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 47.0
Fund 49.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PBE +23.93%
PJP +28.09%
Spread: +4.16 pp (PJP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PBE TTM Op. Margin: N/A
PJP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PBE vs PJP. Trailing 12-month operating profitability (PBE N/A vs PJP N/A) and valuation multiples (PBE N/M vs PJP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PBE | PJP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 71% ($76โ$105) | 93% ($99โ$133) | Stronger Trend | PJP |
| Beta / 30D Volatility Risk Regime | 0.74ฮฒ ยท 28% Vol | 0.45ฮฒ ยท 23% Vol | Lower Realized Risk | PJP |
| Unified Institutional Score Composite Signal | 53.2 / 100 (HOLD) | 50.1 / 100 (HOLD) | Higher Composite | PBE |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PBE vs PJP Buy Guide
PBE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
PJP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PBE nor PJP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.